AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
IMPROVED DOCTOR PATIENT COMMUNICATION INDEXES IN ONCOLOGY - RESULTS OF A PROSPECTIVE, CONTROLLED EVALUATION AND INTERVENTION BASED ON THE E4 MODEL/
Authors: BOURKE T CARR A FENNELLY D MCDERMOTT E CROWN J
Citation: T. Bourke et al., IMPROVED DOCTOR PATIENT COMMUNICATION INDEXES IN ONCOLOGY - RESULTS OF A PROSPECTIVE, CONTROLLED EVALUATION AND INTERVENTION BASED ON THE E4 MODEL/, Annals of oncology, 9, 1998, pp. 677-677
LACK OF INCREASED CARDIAC TOXICITY WITH SEQUENTIAL DOXORUBICIN AND PACLITAXEL
Authors: HUDIS C RICCO L SEIDMAN A BASELGA J CURRIE V FENNELLY D GILEWSKI T LEBWOHL D MOYNAHAN M RAPTIS G SURBONE A SKLARIN N YAO TJ KEEFE D NORTON L
Citation: C. Hudis et al., LACK OF INCREASED CARDIAC TOXICITY WITH SEQUENTIAL DOXORUBICIN AND PACLITAXEL, Cancer investigation, 16(2), 1998, pp. 67-71
PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER
Authors: AGHAJANIAN C FENNELLY D SHAPIRO F WALTZMAN R ALMADRONES L OFLAHERTY C OCONNER K VENKATRAMAN E BARAKAT R CURTIN J BROWN C REICH L WUEST D NORTON L HOSKINS W SPRIGGS DR
Citation: C. Aghajanian et al., PHASE-II STUDY OF DOSE-DENSE HIGH-DOSE CHEMOTHERAPY TREATMENT WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS PRIMARY-TREATMENT FOR PATIENTS WITH ADVANCED OVARIAN-CANCER, Journal of clinical oncology, 16(5), 1998, pp. 1852-1860
NEW CHEMOTHERAPY COMBINATIONS WITH DOCETAXEL IN THE TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER
Authors: DONNELLAN P ARMSTRONG J ROWAN S FENNELLY D LYNCH V MCDONNELL T MCNICHOLAS W CROWN J
Citation: P. Donnellan et al., NEW CHEMOTHERAPY COMBINATIONS WITH DOCETAXEL IN THE TREATMENT OF PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 25(3), 1998, pp. 20-23
PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER
Authors: HUDIS C RICCIO L HOLMES F SEIDMAN A BASELGA J CURRIE V FENNELLY D GILEWSKI T MOYNAHAN M RAPTIS G SKLARIN N SURBONE A UHLENHOPP M MAICKEL N YAO TJ HELLMAN S USAKEWICZ J HORTOBAGYI G NORTON L
Citation: C. Hudis et al., PHASE-II STUDY OF SEMISYNTHETIC PACLITAXEL IN METASTATIC BREAST-CANCER, European journal of cancer, 33(13), 1997, pp. 2198-2202
PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL ADMINISTERED WEEKLY IN PATIENTS WITH RELAPSED OVARIAN-CANCER
Authors: FENNELLY D AGHAJANIAN C SHAPIRO F OFLAHERTY C MCKENZIE M OCONNOR C TONG W NORTON L SPRIGGS D
Citation: D. Fennelly et al., PHASE-I AND PHARMACOLOGICAL STUDY OF PACLITAXEL ADMINISTERED WEEKLY IN PATIENTS WITH RELAPSED OVARIAN-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 187-192
SALVAGE INTRAPERITONEAL THERAPY OF ADVANCED EPITHELIAL OVARIAN-CANCER- IMPACT OF RETROPERITONEAL NODAL DISEASE
Authors: BARAKAT RR FENNELLY D PIZZUTO F VENKATRAMAN ES BROWN C CURTIN JP
Citation: Rr. Barakat et al., SALVAGE INTRAPERITONEAL THERAPY OF ADVANCED EPITHELIAL OVARIAN-CANCER- IMPACT OF RETROPERITONEAL NODAL DISEASE, European journal of gynaecological oncology, 18(3), 1997, pp. 161-163
SALVAGE WEEKLY PACLITAXEL IN RECURRENT OVARIAN-CANCER
Authors: ABURUSTUM NR AGHAJANIAN C BARAKAT RR FENNELLY D SHAPIRO F SPRIGGS D
Citation: Nr. Aburustum et al., SALVAGE WEEKLY PACLITAXEL IN RECURRENT OVARIAN-CANCER, Seminars in oncology, 24(5), 1997, pp. 62-67
THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS
Authors: FENNELLY D KELSEN DP
Citation: D. Fennelly et Dp. Kelsen, THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS, Hepato-gastroenterology, 43(8), 1996, pp. 356-362
SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE
Authors: HUDIS C SEIDMAN A RAPTIS G FENNELLY D GILEWSKI T BASELGA J THEODOULOU M SKLARIN N MOYNAHAN M SURBONE A CURRIE V LEBWOHL D UHLENHOPP M CROWN J NORTON L
Citation: C. Hudis et al., SEQUENTIAL ADJUVANT THERAPY - THE MEMORIAL-SLOAN-KETTERING-CANCER-CENTER EXPERIENCE, Seminars in oncology, 23(1), 1996, pp. 58-64
AVASCULAR NECROSIS FOLLOWING EXTENSIVE CHEMOTHERAPY AND DEXAMETHASONETREATMENT IN A PATIENT WITH ADVANCED OVARIAN-CANCER - CASE-REPORT ANDREVIEW OF THE LITERATURE
Authors: GOGAS H FENNELLY D
Citation: H. Gogas et D. Fennelly, AVASCULAR NECROSIS FOLLOWING EXTENSIVE CHEMOTHERAPY AND DEXAMETHASONETREATMENT IN A PATIENT WITH ADVANCED OVARIAN-CANCER - CASE-REPORT ANDREVIEW OF THE LITERATURE, Gynecologic oncology, 63(3), 1996, pp. 379-381
THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER
Authors: GOGAS H SHAPIRO F AGHAJANIAN C FENNELLY D ALMADRONES L HOSKINS WJ SPRIGGS DR
Citation: H. Gogas et al., THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER, Gynecologic oncology, 61(1), 1996, pp. 22-26
DOSE INTENSITY IN ADVANCED OVARIAN-CANCER - HAVE WE ANSWERED THE QUESTION
Authors: FENNELLY D
Citation: D. Fennelly, DOSE INTENSITY IN ADVANCED OVARIAN-CANCER - HAVE WE ANSWERED THE QUESTION, Clinical cancer research, 1(6), 1995, pp. 575-582
RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: VAHDAT L RAPTIS G FENNELLY D HAMILTON N REICH L TIERSTEN A HARRISON M HUDIS C MOORE M YAO TJ NORTON L CROWN J
Citation: L. Vahdat et al., RAPIDLY CYCLED COURSES OF HIGH-DOSE ALKYLATING-AGENTS SUPPORTED BY FILGRASTIM AND PERIPHERAL-BLOOD PROGENITOR CELLS IN PATIENTS WITH METASTATIC BREAST-CANCER, Clinical cancer research, 1(11), 1995, pp. 1267-1273
HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES
Authors: CROWN J RAPTIS G HAMILTON N FENNELLY D VAHDAT L NORTON L
Citation: J. Crown et al., HIGH-DOSE CHEMOTHERAPY OF BREAST-CANCER - CURRENT STATUS AND DEVELOPMENTAL STRATEGIES, European journal of cancer, 31A(5), 1995, pp. 809-811
PHASE-I STUDY OF TAXOL ADMINISTERED WEEKLY IN PATIENTS WITH PERSISTENT OVARIAN-CANCER
Authors: FENNELLY D SHAPIRO F SPRIGGS D AGHAJANIAN C FRANCIS P LEWIS JL JONES W CURTIN J BARAKAT R HOSKINS W
Citation: D. Fennelly et al., PHASE-I STUDY OF TAXOL ADMINISTERED WEEKLY IN PATIENTS WITH PERSISTENT OVARIAN-CANCER, European journal of cancer, 31A, 1995, pp. 923-923
HIGH-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER - A REVIEW
Authors: VAHDAT L RAPTIS G FENNELLY D CROWN J
Citation: L. Vahdat et al., HIGH-DOSE CHEMOTHERAPY OF METASTATIC BREAST-CANCER - A REVIEW, Cancer investigation, 13(5), 1995, pp. 505-510
DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CYCLOPHOSPHAMIDE, WITH ANALYSIS OF PROGENITOR-CELL MOBILIZATION AND HEMATOLOGIC SUPPORT OF ADVANCED OVARIAN-CANCER PATIENTS RECEIVING RAPIDLY SEQUENCED HIGH-DOSE CARBOPLATIN CYCLOPHOSPHAMIDE COURSES
Authors: FENNELLY D SCHNEIDER J SPRIGGS D BENGALA C HAKES T REICH L BARAKAT R CURTIN J MOORE MAS HOSKINS W NORTON L CROWN J
Citation: D. Fennelly et al., DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CYCLOPHOSPHAMIDE, WITH ANALYSIS OF PROGENITOR-CELL MOBILIZATION AND HEMATOLOGIC SUPPORT OF ADVANCED OVARIAN-CANCER PATIENTS RECEIVING RAPIDLY SEQUENCED HIGH-DOSE CARBOPLATIN CYCLOPHOSPHAMIDE COURSES, Journal of clinical oncology, 13(5), 1995, pp. 1160-1166
SEQUENTIAL ADJUVANT THERAPY WITH DOXORUBICIN PACLITAXEL/CYCLOPHOSPHAMIDE FOR RESECTABLE BREAST-CANCER INVOLVING 4 OR MORE AXILLARY NODES/
Authors: HUDIS CA SEIDMAN AD BASELGA J RAPTIS G LEBWOHL D GILEWSKI T CURRIE V MOYNAHAN ME SKLARIN N FENNELLY D UHLENHOPP M RIEDEL E YAO TJ NORTON L
Citation: Ca. Hudis et al., SEQUENTIAL ADJUVANT THERAPY WITH DOXORUBICIN PACLITAXEL/CYCLOPHOSPHAMIDE FOR RESECTABLE BREAST-CANCER INVOLVING 4 OR MORE AXILLARY NODES/, Seminars in oncology, 22(6), 1995, pp. 18-23
MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER
Authors: SEIDMAN AD HUDIS CA FENNELLY D RAPTIS G BASELGA J NORTON L
Citation: Ad. Seidman et al., MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERIENCE WITH PACLITAXEL IN THE TREATMENT OF BREAST-CANCER, Seminars in oncology, 22(5), 1995, pp. 108-116
HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT
Authors: FENNELLY D VAHDAT L SCHNEIDER J REICH L HAMILTON N HAKES T RAPTIS G WASSERHEIT C KRITZ A GULATI S MARKMAN M HOSKINS W NORTON L CROWN J
Citation: D. Fennelly et al., HIGH-INTENSITY CHEMOTHERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT, Seminars in oncology, 21(2), 1994, pp. 21-25
SIMULTANEOUS DOSE-ESCALATION AND SCHEDULE INTENSIFICATION OF CARBOPLATIN-BASED CHEMOTHERAPY USING PERIPHERAL-BLOOD PROGENITOR CELLS AND FILGRASTIM - A PHASE-I TRIAL
Authors: FENNELLY D WASSERHEIT C SCHNEIDER J HAKES T REICH L CURTIN J YAO TJ MARKMAN M NORTON L CROWN J
Citation: D. Fennelly et al., SIMULTANEOUS DOSE-ESCALATION AND SCHEDULE INTENSIFICATION OF CARBOPLATIN-BASED CHEMOTHERAPY USING PERIPHERAL-BLOOD PROGENITOR CELLS AND FILGRASTIM - A PHASE-I TRIAL, Cancer research, 54(23), 1994, pp. 6137-6142
COMPARATIVE EFFICACY OF BONE-MARROW ENGRAFTMENT FOLLOWING HIGH-DOSE (HD) CARBOPLATIN (CBDCA) PLUS CYCLOPHOSPHAMIDE VERSUS HIGH-DOSE CBDCA TAXOL (TXL), WHEN RESCUED WITH TXL CYCLOPHOSPHAMIDE (CPA) AND GCSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBP)
Authors: FENNELLY D SHAPIRO F SCHNEIDER J SPRIGGS D BENGALA C MCKENZIE M REICH L NORTON L MOORE MAS CROWN J
Citation: D. Fennelly et al., COMPARATIVE EFFICACY OF BONE-MARROW ENGRAFTMENT FOLLOWING HIGH-DOSE (HD) CARBOPLATIN (CBDCA) PLUS CYCLOPHOSPHAMIDE VERSUS HIGH-DOSE CBDCA TAXOL (TXL), WHEN RESCUED WITH TXL CYCLOPHOSPHAMIDE (CPA) AND GCSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PBP), Blood, 84(10), 1994, pp. 10000088-10000088
PERIPHERAL-BLOOD PROGENITOR-CELL (PBP) MOBILIZATION USING TAXOL (T) IN COMBINATION WITH CYCLOPHOSPHAMIDE (C) AND GCSF - QUANTITATION AND CORRELATION OF CD34-FORMING-UNIT GRANULOCYTE-MACROPHAGE (CFU-GM), AND MONONUCLEAR CELL (MNC) COUNT( CELL COUNT, COLONY)
Authors: FENNELLY D BENGALA C SCHNEIDER J REICH L NORTON L SPRIGGS D MOORE MAS CROWN J
Citation: D. Fennelly et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBP) MOBILIZATION USING TAXOL (T) IN COMBINATION WITH CYCLOPHOSPHAMIDE (C) AND GCSF - QUANTITATION AND CORRELATION OF CD34-FORMING-UNIT GRANULOCYTE-MACROPHAGE (CFU-GM), AND MONONUCLEAR CELL (MNC) COUNT( CELL COUNT, COLONY), Blood, 84(10), 1994, pp. 10000105-10000105
TAXOL (TXL) IN COMBINATION WITH CYCLOPHOSPHAMIDE (CTX) AND G-CSF CAN IMPROVE THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORS CELLS (PBPCS)IN UNTREATED LOCALLY ADVANCED OVARIAN-CANCER - PRELIMINARY-REPORT
Authors: BENGALA C FENNELLY D SHAPIRO F SCHNEIDER J REICH L MOORE MAS NORTON L CROWN J
Citation: C. Bengala et al., TAXOL (TXL) IN COMBINATION WITH CYCLOPHOSPHAMIDE (CTX) AND G-CSF CAN IMPROVE THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITORS CELLS (PBPCS)IN UNTREATED LOCALLY ADVANCED OVARIAN-CANCER - PRELIMINARY-REPORT, Blood, 82(10), 1993, pp. 10000082-10000082
Risultati: 1-25 | 26-28